Johnson, David M <br/><br/>
Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections.  [electronic resource] 

 -  Diagnostic microbiology and infectious disease  May 2002 
 - 49-60 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0732-8893 
<br/><br/><label>Standard No.: </label>10.1016/s0732-8893(02)00358-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Community-Acquired Infections--microbiology<br/>Drug Resistance, Multiple, Bacterial<br/>Drug Therapy, Combination--pharmacology<br/>Europe<br/>Gram-Negative Bacteria--drug effects<br/>Gram-Positive Bacteria--drug effects<br/>Humans<br/>Latin America<br/>Microbial Sensitivity Tests<br/>North America<br/>Penicillanic Acid--analogs & derivatives<br/>Piperacillin--pharmacology<br/>Piperacillin, Tazobactam Drug Combination<br/>Respiratory Tract Infections--microbiology<br/>Sentinel Surveillance<br/>Time Factors